コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 which in vivo fluoresces selectively inside peroxisomes.
2 Peroxin (PEX) proteins generate and maintain peroxisomes.
3 e characterized by the absence of functional peroxisomes.
4 dimer facilitates co-transport of Pnc1 into peroxisomes.
5 a-ketoglutarate (alphaKG) in the cytosol and peroxisomes.
6 soprenoid intermediates between plastids and peroxisomes.
7 r NAD(+)-dependent reaction performed inside peroxisomes.
8 ring the cellular requirement for functional peroxisomes.
9 to cell surfaces; instead, it accumulates in peroxisomes.
10 peroxisome size, suggesting that increasing peroxisome abundance can compensate for the deficiencies
12 e present a simple technique for quantifying peroxisome abundance using the small probe Nitro-BODIPY,
13 equires the known peroxisome division factor PEROXISOME AND MITOCHONDRIAL DIVISION FACTOR1 (PMD1).
17 hage inflammatory responses and suggest that peroxisomes are involved in the physiological cessation
27 that epidermal progenitors deficient in the peroxisome-associated protein Pex11b failed to segregate
29 teasome inhibitor or by combining pex26 with peroxisome-associated ubiquitination machinery mutants,
30 We compared this pex12-1 mutant to other peroxisome-associated ubiquitination-related mutants and
33 pared to wild-type PEX6 c.2578C results in a peroxisome biogenesis defect and thus constitutes the ca
35 sive disorders that are caused by defects in peroxisome biogenesis due to bi-allelic mutations in any
37 which the model can be used to conclude that peroxisome biogenesis is dominated by de novo production
39 our studies reveal a novel role for Lrp1 in peroxisome biogenesis, lipid homeostasis, and OPC differ
42 oxisomal membrane proteins (PMPs) traffic to peroxisomes by two mechanisms: direct insertion from the
43 we show that targeting synthetic pathways to peroxisomes can increase the production of fatty-acid-de
46 ety of metabolic pathways are sequestered in peroxisomes, conserved organelles that are essential for
53 These findings expand our understanding of peroxisome division and potentially identify factors con
54 division in a manner that requires the known peroxisome division factor PEROXISOME AND MITOCHONDRIAL
55 thaliana) MAP KINASE17 (MPK17) in affecting peroxisome division in a manner that requires the known
58 o found that N-BODIPY detects aggregation of peroxisomes during final stages of programmed cell death
60 proteins and molecular mechanisms governing peroxisome emergence from the ER are poorly characterize
61 In this issue, Costello et al. identify a peroxisome-ER contact site in human cells held together
63 for storage and transport, mitochondria and peroxisomes for beta-oxidation, and lysosomes for lipid
64 AP-ACBD5-mediated contact between the ER and peroxisomes for organelle maintenance and lipid homeosta
65 d for cell growth in conditions that require peroxisomes for the metabolism of certain carbon sources
67 id, ethylene, and brassinosteroid signaling, peroxisome function, disease resistance, protein phospho
69 ng of peroxisomes to the ER is necessary for peroxisome growth, the synthesis of plasmalogen phosphol
70 crotubule-based organelle transport in which peroxisomes hitchhike on early endosomes and identify Px
71 ncompass identification of genes controlling peroxisome homeostasis and capturing stress-tolerant gen
75 identify a previously unidentified role for peroxisomes in macrophage inflammatory responses and sug
77 ique reported here enables quantification of peroxisomes in plant material at various physiological s
78 enyl butyric acid is an efficient inducer of peroxisomes in various models of murine macrophages, suc
79 ere increased in the conditioned medium from peroxisome-induced macrophages, which blocked LPS-induce
80 e demonstrate that vMIA is also localized at peroxisomes, induces their fragmentation and inhibits th
81 her, production and localization of CD33m in peroxisomes is a way of diminishing the amount of CD33M
82 e between the endoplasmic reticulum (ER) and peroxisomes is necessary for the synthesis and catabolis
85 e-specific autophagy can clear mitochondria, peroxisomes, lysosomes, ER, chloroplasts, and the nucleu
87 The PEX1 ATPase facilitates recycling of the peroxisome matrix protein receptor PEX5 and is the most
88 nes, revealing the ability of BAK to control peroxisome membrane integrity and the release of soluble
90 lastid protein import locus 1 (ppi1) 1] as a peroxisome membrane protein with a regulatory role in pe
93 al. find that loss of VDAC2 diverts BAK into peroxisome membranes, revealing the ability of BAK to co
94 ized, the reactions present in the primitive peroxisomes (microbodies) of algae are poorly understood
95 les (endoplasmic reticulum, Golgi, lysosome, peroxisome, mitochondria and lipid droplet) and show how
96 ACBD5 or VAP expression results in increased peroxisome mobility, suggesting that VAP-ACBD5 complex a
98 n contrast with this view, we show here that peroxisomes move by hitchhiking on early endosomes, an o
99 whereas neither structural difference of the peroxisome network, nor alteration of the respiratory ma
100 various oxidative pathways operating in the peroxisomes of higher plants are fairly well characteriz
101 sing enzymes were targeted to the cytoplasm, peroxisome, or endoplasmic reticulum to generate fatty a
102 t peroxules have a novel role in maintaining peroxisome-organelle interactions in the dynamic environ
105 to the many metabolic functions fulfilled by peroxisomes, PBD pathology is complex and incompletely u
109 metabolic interference with mitochondria and peroxisomes produce an intricate ROS and redox signature
111 f cochlear origin by affecting noise-induced peroxisome proliferation in auditory hair cells and neur
114 s is dynamic; however mechanisms controlling peroxisome proliferation remain poorly understood becaus
116 tarting with peroxule formation, followed by peroxisome proliferation, and finally returning to the n
120 ited the key adipogenic transcription factor peroxisome proliferative activated receptor gamma (PPARg
121 nd their metabolites activate members of the peroxisome proliferative-activated receptor (PPAR) famil
122 rticle, we demonstrate that the nonclassical peroxisome proliferator 4-phenyl butyric acid is an effi
123 essed the hypothesis that variability in the Peroxisome Proliferator Activated Receptor (PPAR) pathwa
124 e glutathione-S-transferase 4-4 (Gsta4(-/-))/peroxisome proliferator activated receptor alpha (Ppara(
125 esponsive element binding protein 1 (CREB1), peroxisome proliferator activated receptor alpha (PPARA)
126 f human chorionic gonadotropin (hCGbeta) and peroxisome proliferator activated receptor gamma (PPARga
127 chain amino acids (BCAA), and regulation of peroxisome proliferator activated receptor gamma (PPARga
128 ty to activate the nuclear hormone receptor, peroxisome proliferator activated receptor gamma (PPARga
130 e dismutase, mitochondrial KATP channels and peroxisome proliferator activated receptor gamma coactiv
132 ect of PERC on bodyweight loss, induction of peroxisome proliferator activated receptor-alpha (PPARal
133 ificant alterations in pathways regulated by peroxisome proliferator activated receptor-gamma (PPARga
134 Computational analysis identified three peroxisome proliferator response elements (PPREs) within
139 bound by the adipocytic transcription factor peroxisome proliferator-activated receptor (PPAR) gamma,
140 a models, we report that CD8(+) TILs enhance peroxisome proliferator-activated receptor (PPAR)-alpha
141 nt receptor potential vanilloid (TRPV)-1 and peroxisome proliferator-activated receptor (PPAR)-alpha.
142 ipogenesis (+30% Oil Red O stain [ORO], +50% peroxisome proliferator-activated receptor (PPAR)-gamma
144 chanistic target of rapamycin (mTOR) and the peroxisome proliferator-activated receptor (PPAR)-gamma
145 into lipid-laden adipocytes by upregulating peroxisome proliferator-activated receptor (PPARgamma) a
146 to a putatively advantageous allele for the peroxisome proliferator-activated receptor A (PPARA) gen
147 receptor type 1 (CB1) or type 2 (CB2) or via peroxisome proliferator-activated receptor alpha (PPAR-a
148 adipocytes by controlling the expression of peroxisome proliferator-activated receptor alpha (Ppara)
150 n, Acot1 knockdown reduced the expression of peroxisome proliferator-activated receptor alpha (PPARal
151 igated whether Astragaloside IV can activate peroxisome proliferator-activated receptor alpha (PPARal
153 such as bezafibrate, known activators of the peroxisome proliferator-activated receptor alpha (PPARal
154 ific DRE that overlaps binding sequences for peroxisome proliferator-activated receptor alpha (PPARal
155 and stabilizes the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARal
156 ecular analysis unraveled that inhibition of peroxisome proliferator-activated receptor alpha activit
157 gene is an AMP-activated protein kinase and peroxisome proliferator-activated receptor alpha respons
159 Falpha (3.0-fold), whereas the expression of peroxisome proliferator-activated receptor alpha target
160 ment binding protein-hepatocyte specific and peroxisome proliferator-activated receptor alpha, which
163 Mechanistically, a HFD induces a robust peroxisome proliferator-activated receptor delta (PPAR-d
166 Moreover, FAs from higher lipolysis activate peroxisome proliferator-activated receptor delta to indu
167 with markedly diminished ability to activate peroxisome proliferator-activated receptor gamma (MSDC-0
168 We studied interactions between polar bear peroxisome proliferator-activated receptor gamma (pbPPAR
170 ng through the intracellular butyrate sensor peroxisome proliferator-activated receptor gamma (PPAR-g
171 CL10 and IL-6 transcript levels, and induced peroxisome proliferator-activated receptor gamma (PPAR-g
172 action between OmpA and Ecgp96 downregulates peroxisome proliferator-activated receptor gamma (PPAR-g
173 restored expression of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-g
174 on of several of its target genes, including peroxisome proliferator-activated receptor gamma (PPARG)
175 een in a Pten-null background, we identified peroxisome proliferator-activated receptor gamma (Pparg)
177 miR-503 expression is directly regulated by peroxisome proliferator-activated receptor gamma (PPARga
178 und that this defect is because of defective peroxisome proliferator-activated receptor gamma (PPARga
183 ancer-binding protein alpha (C/EBPalpha) and peroxisome proliferator-activated receptor gamma (PPARga
186 pha), C/EBPbeta, C/EBPdelta, KLF5, KLF9, and peroxisome proliferator-activated receptor gamma (PPARga
188 d the extracellular matrix, particularly the peroxisome proliferator-activated receptor gamma (Pparga
190 lipid droplet formation and the induction of peroxisome proliferator-activated receptor gamma (PPARga
191 gh levels of TNF and IL-12 but low levels of peroxisome proliferator-activated receptor gamma (PPARga
192 anoparticle (NP) platforms to deliver either Peroxisome Proliferator-Activated Receptor gamma (PPARga
193 their direct action on the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
194 ich was recruited to the promoter of Nox1, a peroxisome proliferator-activated receptor gamma (PPARga
195 iated macrophage differentiation by cleaving peroxisome proliferator-activated receptor gamma (PPARga
196 tion depends on interactions between Sp1 and peroxisome proliferator-activated receptor gamma (PPARga
198 ver development by suppressing expression of peroxisome proliferator-activated receptor gamma 2 and l
199 ented the inflammatory response dependent on peroxisome proliferator-activated receptor gamma activit
200 N-terminal kinase inhibitor SP600125 and the peroxisome proliferator-activated receptor gamma agonist
201 lta-prostaglandin J2-dependent activation of peroxisome proliferator-activated receptor gamma and mac
202 ated protein 2 expression and suppression of peroxisome proliferator-activated receptor gamma and p27
203 s, including uncoupling protein 1 (Ucp1) and peroxisome proliferator-activated receptor gamma co-acti
205 Here we demonstrate that the coactivator peroxisome proliferator-activated receptor gamma coactiv
206 tably, the mitochondrial DNA copy number and peroxisome proliferator-activated receptor gamma coactiv
207 ouse, these UCP1(+) cells also expressed the peroxisome proliferator-activated receptor gamma coactiv
210 evels and the expression of four isoforms of peroxisome proliferator-activated receptor gamma coactiv
211 chondrial transcription factor A (TFAM), and peroxisome proliferator-activated receptor gamma coactiv
212 idrug resistance-associated protein 2 and 4, peroxisome proliferator-activated receptor gamma coactiv
213 ated the role of ERK1/2 on the expression of peroxisome proliferator-activated receptor gamma coactiv
214 uction and ATP levels, reduced expression of peroxisome proliferator-activated receptor gamma coactiv
215 ssion, potentially through the regulation of peroxisome proliferator-activated receptor gamma coactiv
216 nd ZR75.1 breast cancer cells, IGF-1 induces peroxisome proliferator-activated receptor gamma coactiv
217 Here we demonstrate, unexpectedly, that peroxisome proliferator-activated receptor gamma coactiv
219 gnature genes uncoupling protein (UCP)-1 and peroxisome proliferator-activated receptor gamma coactiv
220 but was independent of the activation of the peroxisome proliferator-activated receptor gamma coactiv
221 e Huh7, the coexpression of the coactivators peroxisome proliferator-activated receptor gamma coactiv
222 city are known to regulate and interact with peroxisome proliferator-activated receptor gamma coactiv
223 that fuses paired box gene 8 (PAX8) with the peroxisome proliferator-activated receptor gamma gene (P
224 nase 2, 15-deoxy Delta-prostaglandin J2, and peroxisome proliferator-activated receptor gamma in this
226 BPD that is not dependent on the decrease in peroxisome proliferator-activated receptor gamma levels.
227 c-Jun N-terminal kinase, thereby inhibiting peroxisome proliferator-activated receptor gamma through
229 ing STAT3, STAT6, Kruppel-like factor 4, and peroxisome proliferator-activated receptor gamma, and ca
230 he mitochondrial transcriptional coactivator peroxisome proliferator-activated receptor gamma, coacti
231 nd import of the transcriptional coactivator peroxisome proliferator-activated receptor gamma-coactiv
232 e injections in rats were reported to induce peroxisome proliferator-activated receptor gamma-depende
233 gulating macrophage lipid metabolism through peroxisome proliferator-activated receptor gamma-depende
238 phosphatases, and ameliorated activation of peroxisome proliferator-activated receptor gamma/sterol
239 Tfe3, control the regulator of adipogenesis, peroxisome proliferator-activated receptor gamma2 (Pparg
240 of inflammatory mediators and repression of peroxisome proliferator-activated receptor signaling and
241 n metabolic pathways, some linked to altered peroxisome proliferator-activated receptor signaling, mu
242 the first week due to failure to undergo the peroxisome proliferator-activated receptor signaling-dep
244 sepsis and to identify the mechanism whereby peroxisome proliferator-activated receptor-alpha confers
247 gulation of nhr-49 (an ortholog of the human peroxisome proliferator-activated receptor-alpha), and a
250 elpar is a potent, selective agonist for the peroxisome proliferator-activated receptor-delta (PPAR-d
251 growth hormone secretagogue ibutamoren, the peroxisome proliferator-activated receptor-delta agonist
252 wk with rosiglitazone, a specific agonist of peroxisome proliferator-activated receptor-gamma (PPAR-g
253 the upregulation of the transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-g
254 d patients with NAFLD, hepatic expression of peroxisome proliferator-activated receptor-gamma (PPARG)
255 13.1 treatment were associated with enhanced peroxisome proliferator-activated receptor-gamma (PPARga
257 but improvement of insulin resistance using peroxisome proliferator-activated receptor-gamma (PPARga
258 X receptors alpha and beta (LXRalpha,beta), peroxisome proliferator-activated receptor-gamma (PPARga
260 a healthy human (mini-)organ, and show that peroxisome proliferator-activated receptor-gamma agonist
262 ented and even partially reversed ex vivo by peroxisome proliferator-activated receptor-gamma agonist
264 mediated by the transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactiv
265 cal exercise and thyroid hormone mediate the peroxisome proliferator-activated receptor-gamma coactiv
267 (-/-) OPCs with cholesterol or activation of peroxisome proliferator-activated receptor-gamma with pi
268 ease of a transferable factor able to induce peroxisome proliferator-activated receptor-gamma-mediate
269 roxynonenal) released from the heart trigger peroxisome proliferator-activated receptor-gamma-mediate
274 NRs for treating metabolic diseases are the peroxisome proliferator-activated receptors (PPARs), PPA
275 th 14 other nuclear receptors, including the peroxisome proliferator-activated receptors (PPARs).
277 al LPS exposure led to pre-existing elevated peroxisome proliferators-activated receptor-gamma co-act
278 ssociated protein Pex11b failed to segregate peroxisomes properly and entered a mitotic delay that pe
280 ulate the hallmarks of PBDs, like absence of peroxisomes, reduced viability, neurodegeneration, mitoc
281 e alleles: pex1-2 and pex1-3pex1-2 displayed peroxisome-related defects accompanied by reduced PEX1 a
283 that biosynthesis of these chemicals in the peroxisomes results in significantly decreased accumulat
284 Finally, our data reveal subpopulations of peroxisomes showing only weak colocalization between PEX
285 , PEX14, and PEX11 around actively importing peroxisomes, showing distinct differences between these
286 defects, including the restoration of normal peroxisome size, suggesting that increasing peroxisome a
287 Of note, CD33 is the only Siglec with a peroxisome-targeting sequence, and this motif emerged by
290 that the msn2Deltamsn4Delta strain had fewer peroxisomes than the wild type, and lipid analysis indic
292 ing the numbers and cellular distribution of peroxisomes through the cytoskeleton-peroxisome connecti
293 be compartmentalized into the matrix of the peroxisome to hijack the medium chain fatty acyl-CoA gen
294 This rapid and efficient translocation of peroxisomes to microtubule minus ends indicates that mam
299 ncies caused by pex1-3 and that the enlarged peroxisomes visible in PEX1/pex1-3 may represent autopha
300 ssociating with core retromer and binding to peroxisomes, which then send the enzyme to LDs via tubul
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。